Disodium Inosinate
USP/1222002 - United States Pharmacopeia (USP) Reference Standard
Synonym: Inosine 5′-monophosphate disodium salt hydrate; 5′-IMP-Na2; 5′-Inosinic acid disodium salt hydrate; I-5′-P; IMP; Inosinic Acid
CAS Number: 352195-40-5
Empirical Formula (Hill Notation): C10H11N4O8PNa2 · xH2O
Molecular Weight: 392.17 (anhydrous basis)
MDL Number: MFCD00150372
Linear Formula: C10H11N4O8PNa2 · xH2O
Product Type: Chemical
API family | disodium inosinate |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C10H13N4O8P.2Na.H2O/c1 |
InChI key | KQCIGEIXDXQSGM-MSQVLRTGSA |
manufacturer/tradename | USP |
SMILES string | [Na+].[Na+].O[C@H]1[C@@H] |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Disodium Inosinate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
Biochem/physiol Actions: | Inosine monophosphate, or inosinic acid, is the ribonucleotide of hypoxanthine and the first nucleotide formed during purine synthesis. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |